Tolerability of Alternative Dosing Schedules for Sunitinib: A Systematic Review and Meta-Analysis.

Published in: Yonsei medical journal (2020)

This meta-analysis suggests that a 2/1 schedule of sunitinib lowers the risk of fatigue and the occurrence other AEs without compromising efficacy.

Keyphrases